Mycotoxin Testing Supplements: Aflatoxins, Ochratoxin A, Fumonisins

Mycotoxins are toxic secondary metabolites produced by molds (fungi) that can contaminate botanical ingredients, grains, and other agricultural raw materials used in dietary supplements. Lab testing for mycotoxins in supplements uses LC-MS/MS to detect and quantify the most common and hazardous mycotoxins: aflatoxins (B1, B2, G1, G2), ochratoxin A, fumonisins (B1, B2, B3), and sometimes zearalenone, deoxynivalenol (DON), and T-2/HT-2 toxins. Because mycotoxins are potent at very low concentrations (parts per billion), testing requires highly sensitive analytical methods and careful sampling to ensure representative results.

Botanical ingredients that have been improperly dried or stored in humid conditions are at highest risk for mycotoxin contamination. Ingredients like nuts (especially peanuts for aflatoxins), grains, spices, coffee, cocoa, and dried herbs can support mold growth and mycotoxin production at any point from harvest through storage. This article covers the LC-MS/MS methods used for mycotoxin testing, ingredients most at risk, regulatory limits, and practical testing guidance for supplement brands.

LC-MS/MS Mycotoxin Detection

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for mycotoxin testing in complex supplement matrices. The method combines the separation power of HPLC with the specificity and sensitivity of triple quadrupole mass spectrometry. Multiple reaction monitoring (MRM) transitions are set up for each mycotoxin, providing both quantitative data and confirmatory fragment ions that verify the identity of each detected mycotoxin.

A typical multi-mycotoxin LC-MS/MS panel covers 5-12 mycotoxins simultaneously. The sample is extracted with an organic solvent mixture (commonly acetonitrile-water with formic acid), cleaned up using solid-phase extraction (SPE) or immunoaffinity columns to remove matrix interferences, and then analyzed. Detection limits are typically 0.1-1.0 ppb (mcg/kg) for aflatoxins, 0.5-2.0 ppb for ochratoxin A, and 10-50 ppb for fumonisins.

Isotope-labeled internal standards (such as 13C-aflatoxin B1) are used to correct for matrix effects and recovery losses, improving accuracy. Labs with ISO 17025 accreditation for mycotoxin testing should demonstrate their method's performance through proficiency testing programs such as FAPAS or BIPEA.

⚠️ Note

Mycotoxin contamination is often heterogeneous -- a single contaminated kernel or plant fragment in a large batch can produce a "hot spot." Standard grab sampling may miss contamination if not sufficiently representative. Follow a defined sampling plan (such as USP <561> or EU 401/2006) that specifies the number of incremental samples, sample size, and compositing procedure. The lab can advise on appropriate sampling protocols.

Ingredients Most at Risk for Mycotoxins

Not all supplement ingredients carry the same mycotoxin risk. Understanding which ingredients are susceptible helps prioritize testing resources.

High-risk ingredients include peanuts, tree nuts, maize (corn), wheat, rice, other cereal grains, spices (particularly chili pepper, black pepper, turmeric, paprika), coffee, cocoa, and dried fruits. These ingredients support Aspergillus, Penicillium, and Fusarium mold growth under warm, humid conditions and have a well-documented history of mycotoxin contamination.

Medium-risk ingredients include oilseeds (sunflower, sesame), soy products, dried herbs and botanicals (especially those from tropical regions), and protein powders derived from grains. These can support mold growth if improperly dried.

Low-risk ingredients include purified chemicals (isolated vitamins, minerals, amino acids), highly processed extracts, and synthetic compounds. These are unlikely to support mold growth and mycotoxin production.

Botanicals sourced from tropical and subtropical regions, particularly those with seasonal rainfall and limited drying infrastructure, should be prioritized for mycotoxin testing regardless of the specific ingredient.

Aflatoxins: The Highest Priority

Aflatoxins (B1, B2, G1, G2) are produced primarily by Aspergillus flavus and Aspergillus parasiticus. Aflatoxin B1 is classified by the IARC as a Group 1 human carcinogen (known to cause liver cancer) and is the most toxicologically significant mycotoxin. The sum of aflatoxins (B1+B2+G1+G2) is typically regulated together.

US FDA action levels for aflatoxins in human food are 20 ppb total aflatoxins, with some commodities having lower limits. The European Union has set stricter limits: 2 ppb for aflatoxin B1 and 4 ppb total aflatoxins in dietary supplements, though exact limits vary by product category. Brands selling into both US and EU markets should design specifications to meet the most stringent applicable limit.

Peanuts and peanut-derived ingredients (peanut protein, peanut flour) are the classic aflatoxin-risk matrix. Other ingredients frequently tested for aflatoxins include tree nuts, corn-based ingredients, rice protein, spices, and milk thistle (Silybum marianum) seeds. Product recalls due to aflatoxin contamination have occurred across multiple supplement and food categories.

Ochratoxin A and Fumonisins

Ochratoxin A (OTA) is produced by Penicillium and Aspergillus species and is nephrotoxic (kidney-damaging) and possibly carcinogenic. It is most commonly found in cereals, coffee, cocoa, dried vine fruits, and spices. EU limits for OTA in dietary supplements are typically 5-10 ppb, though limits are commodity-specific. The US has not established regulatory limits for OTA in dietary supplements, but GMP requirements under 21 CFR 111 obligate manufacturers to test for contaminants that may be present.

Fumonisins (B1, B2, B3) are produced by Fusarium species and are most commonly associated with corn (maize). Fumonisin B1 is classified as possibly carcinogenic. While fumonisins are more associated with animal feed and corn-based foods, any supplement containing corn-derived ingredients (maltodextrin, corn starch, corn protein) could carry fumonisin risk. EU limits for fumonisins are typically 1,000-4,000 ppb for corn products intended for human consumption.

Quick Reference

Lab Category Matching

Real Methods Explained

What Sample to Send

For mycotoxin testing, sample quantity depends on the sampling plan. A minimum of 100-250 grams of ground, homogenized material is typical for a representative sample. For finished products (capsules, tablets), send at least 50-100 grams after grinding. For whole botanical ingredients (whole nuts, seeds, dried herbs), grind and homogenize before shipping an aliquot, or send a larger amount and ask the lab to grind and homogenize. Because mycotoxin contamination can be heterogeneously distributed, larger sample sizes improve the probability of detecting contamination.

Expected Turnaround Time

Price Ranges

Country/Region Targeting

Mycotoxin regulations vary significantly by country. The EU has the most comprehensive and stringent mycotoxin limits, set by Commission Regulation (EC) No 1881/2006 and subsequent amendments, with specific limits for aflatoxins, OTA, fumonisins, DON, zearalenone, and others across different commodities. The US FDA has established action levels for aflatoxins but fewer specific limits for other mycotoxins in supplements. Japan, Korea, China, and other Asian markets each have their own mycotoxin standards. When exporting supplements, verify the mycotoxin limits in each destination country and ensure your testing program addresses all regulated mycotoxins.

FAQ

Q: What mycotoxins should my supplement testing program cover?

At minimum, aflatoxins (B1, B2, G1, G2) and ochratoxin A should be included in any botanical supplement mycotoxin program. Add fumonisins if your product contains corn, corn-derived ingredients, or rice. Add deoxynivalenol (DON) and zearalenone for grain-based ingredients. Tailor your panel to your ingredient risk profile -- a spice-heavy formula needs a broader panel than a product based on purified vitamins and minerals. Discuss your ingredient list with the lab to identify the appropriate mycotoxin panel.

Q: How often should I test for mycotoxins?

Frequency depends on ingredient risk, supplier history, and storage conditions. High-risk ingredients (peanuts, nuts, spices, grains from humid regions) should be tested every lot. Medium-risk botanicals should be tested on a defined frequency, such as every third lot or quarterly, with increased frequency if any lot tests positive. Low-risk ingredients may be tested annually or based on a skip-lot testing program. Document your mycotoxin testing frequency in your quality plan and adjust based on data trends.

Q: Is ELISA testing sufficient for mycotoxins?

ELISA kits offer a lower-cost screening option for individual mycotoxins or classes (total aflatoxins, OTA). They can be useful for routine screening of high-risk lots, but positive ELISA results should be confirmed by LC-MS/MS. ELISA can produce false positives due to cross-reactivity with matrix components or structurally similar compounds. For regulatory or commercial documentation (e.g., a COA for a retailer), LC-MS/MS data from an ISO 17025 accredited lab is expected.

Q: Can organic supplements skip mycotoxin testing?

No. Organic certification addresses agricultural practices (no synthetic pesticides, no GMOs) but does not eliminate mycotoxin risk. In fact, the absence of synthetic fungicides in organic farming may increase the risk of fungal growth and mycotoxin production under some conditions. Organic supplements should be tested for mycotoxins with the same rigor as conventional supplements. Do not assume organic equals mycotoxin-free.

Q: How should I handle a lot that tests positive for mycotoxins?

A positive mycotoxin result above your specification limit requires investigation and corrective action. First, confirm the result with a retest of a new, independently drawn sample from the same lot. If the positive result is confirmed, the lot should be rejected or reworked (if rework is feasible and the contaminant can be removed). Investigate the root cause: Was the ingredient improperly dried? Stored in humid conditions? Sourced from a high-risk region? Use the findings to strengthen your supplier qualification, incoming material specifications, and storage procedures. Document the investigation and disposition decision per GMP requirements.

Get lab testing quotes ->